Home
>
National Drug Code (NDC)
>
PhosLo
PhosLo - 49230-640-21 - (Calcium Acetate)
Drug Information of PhosLo
| Product NDC: | 49230-640 |
| Proprietary Name: | PhosLo |
| Non Proprietary Name: | Calcium Acetate |
| Active Ingredient(s): | 667 mg/1 & nbsp; Calcium Acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PhosLo
| Product NDC: | 49230-640 |
| Labeler Name: | Fresenius Medical Care North America |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021160 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20010402 |
Package Information of PhosLo
| Package NDC: | 49230-640-21 |
| Package Description: | 200 CAPSULE in 1 BOTTLE (49230-640-21) |
NDC Information of PhosLo
| NDC Code | 49230-640-21 |
| Proprietary Name | PhosLo |
| Package Description | 200 CAPSULE in 1 BOTTLE (49230-640-21) |
| Product NDC | 49230-640 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Calcium Acetate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20010402 |
| Marketing Category Name | NDA |
| Labeler Name | Fresenius Medical Care North America |
| Substance Name | CALCIUM ACETATE |
| Strength Number | 667 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] |
